
Impilo acquires The Fertility Partnership
Swedish investment firm Impilo has acquired a controlling majority stake in The Fertility Partnership (TFP) from White Cloud Capital, founders and minority shareholders.
TFP is an overarching entity that is the majority or outright owner of the individual clinics, with founding doctors typically holding minority ownership positions.
The founders and clinic-level minority shareholders will retain a significant minority holding in the group and their individual clinics respectively.
Following the transaction, Impilo will support the expansion of TFP's offering in the UK and Poland, and its growth plans into new countries.
Previous funding
TFP was founded in 2012 with the merger of Oxford Fertility (a spinout from Oxford University Hospital) and IVF Hammersmith (closely associated with Imperial College London Hospital). White Cloud Capital provided funding to support the transaction.
Company
TPF has revenues of approximately £51m and employs approximately 600 staff. It is a provider of fertility services, ultrasound pregnancy scans and hormone treatments. The group comprises eight IVF clinics in the UK, supported by 27 satellites, two IVF clinics in Poland, a network of 88 ultrasound clinics across the UK and a nascent hormone treatment business.
People
Impilo – Hans-Christian Bødker Jensen (partner).
The Fertility Partnership – Andrew Came (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater